Hypothalamus-pituitary-adrenal axis in central diabetes insipidus: ACTH and cortisol responsiveness to CRH administration

Journal of Endocrinological Investigation

Volumn 25, Issue 11, 2002, Pages 932-937

  Pivonello, R ^a   Faggiano, A ^a   Filippella, M ^a   Di Somma, C ^a   De Martino, M C ^a   Gaccione, M ^a   Lombardi, G ^a   Colao, Annamaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Adrenal; Arginine vasopressin; Corticotropin; Corticotropin releasing hormone; Diabetes insipidus; Glucocorticoids; Pituitary

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DESMOPRESSIN; FOLLITROPIN; HYDROCORTISONE;

ADOLESCENT; ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DIABETES INSIPIDUS; DRUG EFFECT; EVALUATION; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; POLYDIPSIA; POLYURIA; PROVOCATION TEST; SEX; STANDARD; STATISTICAL SIGNIFICANCE;

EID: 0036958847     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344064     Document Type: Article

References (33)

1. Gwinup G. Test for pituitary function using vasopressin. Lancet 1965, 2: 572-573.
2. Gwinup G. Studies on the mechanism of vasopressin-induced steroid secretion in man. Metabolism 1965, 14: 1282-1286.
3. Gwinup G., Steinberg T., King C.G., Vernikos-Danellis J. Vasopressin-induced ACTH secretion in man. J. Clin. Endocrinol. Metab. 1982, 299: 355-357.
4. Gillies G.E., Linton E.A., Lowry PJ. Corticotropin releasing activity of new CRF is potentiated several times by vasopressin. Nature 1982, 299: 355-357.
5. DeBold C.R., Sheldon W.R., DeCherney G.S. et al. Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. J. Clin. Invest. 1984, 73: 533-538.
6. Lamberts S.W.J., Verleun T., Oosterom R., De Jong F., Hackeng W.H.L. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man. J. Clin. Endocrinol. Metab. 1984, 58: 298-303.
7. Oelkers W. Hyponatriemia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N. Engl. J. Med. 1989, 321: 492-496.
8. Wakui H., Nishinari T., Nishimura S., Endo Y., Nakamoto Y., Miura A.B. Inappropriate secretion of antidiuretic hormone in isolated adrenocorticotropin deficiency. Am. J. Med. Sci. 1991, 301: 319-321.
9. Wittert G.A., Crock P.A., Donald R.A. et al. Arginine vasopressin in Cushing's disease. Lancet 1990, 335: 991-994.
10. Nussey S.S., Page S.R., Peterson D.B. et al. Corticotropin releasing hormone (CRH 1-41) stimulates the secretion of adrenocorticotrophin, vasopressin and oxytocin but not adrenocorticotrophin precursors: Evidence from petrosal sinus sampling in man. Clin. Endocrinol. 1991, 34: 51-56.
11. Colao A., Ferone D., Di Sarno A. et al. Vasopressin levels in Cushing's disease: Inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison with patients without Cushing's disease. Clin. Endocrinol. 1996, 45: 157-166.
12. Colao A., Pivonello R., Ferone D. et al. Effect of corticotropin-releasing hormone on arginine vasopressin and atrial natriuretic factor in patients with Cushing's disease. Clin. Endocrinol. 1998, 49: 77-84.
13. Pivonello R., Colao A., Di Somma C. et al. Impairment of bone status in patients with central diabetes insipidus. J. Clin. Endocrinol. Metab. 1998, 83: 2275-2280.
14. Pivonello R., Faggiano A., Di Somma C. et al. Effect of short-term treatment with alendronate on bone density and bone markers in patients with central diabetes insipidus. J. Clin. Endocrinol. Metab. 1999, 84: 2349-2352.
15. Pivonello R., Faggiano A., Arrichiello P. et al. Central diabetes insipidus and heart: Effect of acute arginine vasopressin deficiency and replacement treatment with desmopressin on cardiac performance. Clin. Endocrinol. 2001, 54: 97-106.
16. Mazza E., Goffi S., Barchi P. et al. Enhanced adrenocorticotropic hormone and cortisol responses to corticotrophin-releasing hormone in central idiopathic diabetes insipidus. Eur. J. Endocrinol. 1994, 130: 121-124.
17. Elias L.L.K., Antunes-Rodrigues J., Elias P.C.L., Moreira A.C. Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus. J. Clin. Endocrinol. Metab. 1997, 82: 1243-1247.
18. Carraro A., Giusti M., Porcella P., Sessarego P., Giordano G. Differing responses of cortisol to oCRF during endonasal and oral treatment with DDAVP. Eur. J. Clin. Invest. 1994, 24: 459-462.
19. Zacharieva S., Andreeva M., Orbetzova M. et al. Effects of corticotropin-releasing hormone on ACTH, cortisol and 13,14-dihydro-15-keto prostaglandin E2 in patients with diabetes insipidus before and after captopril treatment. Prostaglandins Leukot. Essent. Fatty Acids 1996, 54: 433-437.
20. Robertson G.L. Differential diagnosis of polyuria. Annu. Rev. Med. 1988, 39: 425-442.
21. Zerbi R.I., Robertson G.L. A comparison of plasma vasopressin measurements with standard indirect test in the differential diagnosis of polyuria. N. Engl. J. Med. 1981, 305: 1539-1549.
22. Blotner H. Primary and idiopathic diabetes insipidus: A system disease. Metabolism 1958, 7: 191-200.
23. Recht L.D., Hoffman D.L., Haldar J., Silverman A.J., Zimmerman E. Vasopressin concentrations in hypophyseal portal plasma: Insignificant reduction following removal of the posterior pituitary gland. Neuroendocrinology 1981, 33: 88-90.
24. Lechan R.M. Neuroendocrinology of pituitary hormone regulation. Endocrinol. Metab. Clin. North Am. 1987, 16: 475-501.
25. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 1991, 43: 425-473.
26. Orth D.N. Corticotropin-releasing hormone in humans. Endocr. Rev. 1992, 13: 164-191.
27. Antaraki A., Rangou D., Chlouverakis C. The renin-aldosterone axis in patients with diabetes insipidus. Clin. Endocrinol. 1994, 40: 505-510.
28. Spinedi E., Negro-Vilar A. Angiotensin II and ACTH release: Site of action and potency relative to corticotropin releasing factor and vasopressin. Neuroendocrinology 1983, 37: 446-453.
29. Singh A., Petrides J.S., Gold P.W., Chrousos G.P., Deuster P.A. Differential hypothalamic-pituitary-adrenal axis reactivity to psychological and physical stress. J. Clin. Endocrinol. Metab. 1999, 84: 1944-1948.
30. Holmes M.C., Catt K.J., Aguilera G. Involvement of vasopressin in the down-regulation of pituitary corticotropin-releasing factor receptors after adrenalectomy. Endocrinology 1987, 121: 2093-2098.
31. Kopin I.J. Definition of stress and sympathetic neuronal responses. Ann. N.Y. Acad. Sci. 1995, 771: 19-30.
32. Kline R.L., Patel K.L., Mercer P.F. Enhanced noradrenergic activity in the kidney of Brattleboro rats with diabetes insipidus. Am. J. Physiol. 1986, 250: R567-R572.
33. Axelrod J., Reisine T.D. Stress hormones: Their interaction and regulation. Science 1984; 224: 452-459.